Get started
Author

Marine Karchava

Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA experience
2017 · Ekaterine Dolmazashvili, Akaki Abutidze, et al. · European Journal of Gastroenterology & Hepatology · 83
Prevalence of Drug-Resistance Mutations and Non-Subtype B Strains Among HIV-Infected Infants From New York State
2006 · Marine Karchava, Wendy Pulver, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 42
High incidence of the hepatitis C virus recombinant 2k/1b in Georgia: Recommendations for testing and treatment
2015 · Marine Karchava, Jesper Waldenström, et al. · Hepatology Research · 28
Characterization of HIV‐1 subtypes and drug resistance mutations among individuals infected with HIV in Georgia
2012 · Natia Dvali, Monica M. Parker, et al. · Journal of Medical Virology · 17
Epidemiology of human immunodeficiency virus (HIV) drug resistance in HIV patients with virologic failure of first‐line therapy in the country of Georgia
2018 · Ekaterine Karkashadze, Natia Dvali, et al. · Journal of Medical Virology · 14
The natural history of recent hepatitis C virus infection among blood donors and injection drug users in the country of Georgia
2016 · Tengiz Tsertsvadze, Lali Sharvadze, et al. · Virology Journal · 13
PDF
Virologic outcomes of second-line antiretroviral therapy in Eastern European country of Georgia
2014 · Nikoloz Chkhartishvili, Lali Sharvadze, et al. · AIDS Research and Therapy · 12
PDF
An evaluation of the hepatitis C testing, care and treatment program in the country of Georgia’s corrections system, December 2013 – April 2015
2019 · Aaron M. Harris, Otar Chokoshvili, et al. · BMC Public Health · 11
Impact of hepatitis C virus recombinant form RF1_2k/1b on treatment outcomes within the Georgian national hepatitis C elimination program
2017 · Marine Karchava, Nikoloz Chkhartishvili, et al. · Hepatology Research · 11
IL28B favorable genotype and ultrarapid viral response as the earliest treatment predictors of a sustained viral response in a Georgian cohort infected with the hepatitis C genotype 1
2012 · Marine Karchava, Lali Sharvadze, et al. · European Journal of Gastroenterology & Hepatology · 5
Estimating HIV incidence in eastern European country of Georgia: 2010–2012
2014 · Tengiz Tsertsvadze, Nikoloz Chkhartishvili, et al. · International Journal of STD & AIDS · 4
Procalcitonin as a marker of bacterial sepsis in immunocompromised patients
2012 · Lana Gatserelia, Lali Sharvadze, et al. · Retrovirology · 1
PDF
Epidemiological Profile and Clinical Outcomes of HIV-Associated Malignancies in Georgia: A Five-Year Retrospective Study
2026 · Bolokadze, Natalia, Arghvliani, Mariam, et al. · Translational and Clinical Medicine - Georgian Medical Journal
PDF
Spontaneous HBsAg Loss and Seroconversion in Chronic HBV Patients Following Severe COVID-19: A Five-Year Follow-Up of Three Patients
2024 · Karchava, Marine, Dvali, Natia, et al. · Translational and Clinical Medicine - Georgian Medical Journal
The Significant gap between new HIV infections and new diagnoses in the Eastern European country of Georgia
2018 · Nikoloz Chkhartishvili, Natia Dvali, et al. · Translational and Clinical Medicine - Georgian Medical Journal
Works count: 15
Citation count: 241
H-index: 9
I10-index: 9
Year
Topic
Type